Part of the conference series
Genome Engineering and Synthetic Biology (3rd edition)
25-26 January 2018, Bruges, Belgium
Genome Engineering and Synthetic Biology (3rd edition)
A VIB Tools & Technologies conferences
Genome Engineering and Synthetic Biology are revolutionizing Life Sciences. Driven by advances in the CRISPR-toolbox for rapid, cheap, multiplex modification of genomes and breakthroughs in DNA synthesis technologies, the pace of progress enabled by these tools in the last years has been breathtaking.
The 1st and 2nd Genome Engineering and Synthetic Biology: Tools and Technologies meeting (GESB) in September 2013 and January 2016 were a roaring success and we are pleased to announce the 3rd edition of GESB in picturesque Bruges in January, 2018.
The conference will look at emerging tools & approaches in the field of:
- CRISPR and Synthetic Biology Tools
- Gene and Genome assembly
- Targeted Genome Engineering and Design
- Genetic Circuits and Regulation
- CRISPR Screens
The symposium will bring together some of the most highly regarded Academics and Companies in the world with novel technologies in several sessions. In addition to a great scientific and technology program, the conference will provide ample opportunities to network during the breaks, poster sessions, reception and the conference dinner!
Poster information:
Format: A0 (841 x 1189 mm / 33.1 x 46.8 in), portrait orientation
Confirmed speakers
Program
Day 1 - Thursday, 25 January, 2018
08:45
09:15
Registration & coffee
09:15
09:20
Welcome
Plenary: The Genome Engineering Revolution
Chair: Silvie Van den Hoecke
09:20
09:55
Improving the Safety and Versatility of CRISPR Genome Editing
Benjamin P. Kleinstiver
Harvard Medical School, US
Academic speaker
09:55
10:20
Developing tools and technologies for precision genome editing
Peter Cameron
Senior research scientist, Caribou Biosciences, US
Company speaker
10:20
10:50
Coffee Break
Parallel 1: The Genome Engineering Revolution
Chair: Silvie Van den Hoecke
Chair: Silvie Van den Hoecke
10:50
11:25
Editing, Regulating and Imaging Genome with CRISPR Technology
Mazhar Adli
University of Virginia, US
Academic speaker
11:25
11:50
Mitigating risk of off-target effects when using CRISPR genome editing
Mollie Schubert
Research Scientist, Integrated DNA Technologies, US
Company speaker
11:50
12:25
Precise editing at DNA replication forks enables multiplex genome engineering in Eukaryotes
Farren Isaacs
Yale University, US
Academic speaker
Parallel 2: Next-Generation in Synthetic Biology
Chair: Nico Callewaert
10:50
11:15
Balancing complexity and scale in the Foundry at Ginkgo Bioworks, Inc.
Elaine Shapland
Head of Build, Ginkgo Bioworks, US
Company speaker
11:15
11:50
What DNA origami can help us learn about biology
Björn Högberg
Karolinska Institutet, SE
Academic speaker
11:50
12:15
You Design It, We Build It
Emily LeProust
CEO, Twist Bioscience, US
Company speaker
12:15
12:30
The London DNA Foundry: Using DOE and robotics to enable automated organism engineering
David McClymont
The London DNA Foundry, UK
Selected from abstracts
12:30
13:15
Lunch
13:15
14:00
Poster session
Parallel 3: Tools for CRISPR Control
Chair: Sven Eyckerman
14:00
14:25
Tools for target validation with CRISPR/Cas9
Jon Moore
CSO, Horizon Discovery, UK
Company speaker
14:25
15:00
Inhibition CRISPR-Cas9 with Bacteriophage Proteins
Joseph Bondy-Denomy
UCSF, US
Academic speaker
15:00
15:05
New strategies & insights into CRISPR driven genome editing
Gurpreet Balrey
Global Technical Applications Manager, Merck KGaA, DE
Sponsored talk
15:05
15:30
Event Driven Gene Programming in Adoptive T-cell Therapy
Bing C. Wang
Co-Founder & CEO, Refuge Biotechnologies, US
Company speaker
15:30
16:05
Phages fight back: the functioning and prevalence of anti-CRISPRs
Alan Davidson
University of Toronto, CA
Parallel 4: Engineering and Directed Evolution
Chair: Nico Callewaert
14:00
14:25
Promoter Tuning: Context is Crucial
Paul Feldstein
CEO, Circularis, US
Company speaker
14:25
15:00
Designing and Evolving Novel Chemistry
Sven Panke
ETH Department of Biosystems Science and Engineering, CH
Academic speaker
15:00
15:05
The Echo Acoustic Platform for Synthetic Biology. A Sound Idea!
Anna Lehto
Field Applications Scientist Europe, Labcyte, FI
Sponsored talk
15:05
15:30
Putting the whole genome to work: microbial and protein evolution with novel compound genes created from native protein-coding sequences
Helge Zieler
Founder/ President, Primordial Genetics, US
Company speaker
15:30
16:05
Engineering new functions with consideration of the host cell
Tom Ellis
Imperial College London, UK
Academic speaker
16:05
16:35
Coffee break
Plenary: Advanced CRISPR screens
Chair: Thomas Jacobs
16:35
17:10
Genome-scale genetic screens for cataloging fitness genes in human cells
Jason Moffat
University of Toronto, CA
Academic speaker
17:10
17:35
Optimizing Genetic Profiling and Functional Screening for Genome-Wide Analysis
Paul Diehl
COO, Cellecta Inc., US
Company speaker
17:35
18:10
Development of new CRISPR/Cas9-based tools to study drug interactions through knockout and directed evolution
Michael Bassik
Stanford University, Department of Genetics, US
Academic speaker
18:10
19:10
Reception
20:00
22:30
Conference dinner
Day 2 - Friday, 26 January, 2018
08:45
09:20
Coffee
Plenary: The Synthetic biology Revolution
Chair: Nico Callewaert
09:15
09:55
The Genetic Code in the Age of Synthetic Biology
Dieter Söll
Yale University, US
Academic speaker
09:55
10:20
Evonetix: a novel approach to DNA synthesis
Tim Brears
CEO, Evonetix, UK
Company speaker
10:20
10:50
Coffee break
10:50
11:25
Synthetic Genetics: beyond DNA and RNA
Philipp Holliger
MRC Laboratory of Molecular Biology, Cambridge, UK
Academic speaker
11:25
11:50
Evolution of the BioXp™ – Synthetic Biology Workflows Compressing Design Build Test
Steven Riedmuller
Synthetic Genomics Inc, US
Company speaker
11:50
12:25
Programmable On-Chip DNA Compartments as ‘Artificial Cells’
Roy Bar-Ziv
Weizmann Institute of Science, IL
12:25
13:10
Lunch
13:10
14:00
Poster session
Parallel 5: Targeted Genome Engineering and Design
Chair: Sven Eyckerman
14:00
14:35
Development of platform technologies which facilitate the construction of microbial cell factories
Akihiko Kondo
Kobe University, JP
Academic speaker
14:35
15:00
Enabling CRISPR applications from functional genomics to therapeutics with synthetic sgRNA
Jason Steiner
Director, Business Development, Synthego, US
Company speaker
15:00
15:05
Building DNA libraries for exploring combinatorial design space
Yifan Li
Senior scientist, Genscript, US
Sponsored talk
15:05
15:40
DNA-free genome editing with functional variants of CRISPR genome editing enzymes
Sunghwa Choe
School of Biological Sciences, Seoul National University, KR
Academic speaker
15:40
16:05
Applying high-throughput genome engineering to optimize a variety of microbes for industrial fermentation
Kedar Patel
Director, Zymergen, US
Company speaker
Parallel 6: Next Generation CRISPR application and design
14:00
14:35
Translational CRISPR-Cas9 Genome Editing of Human Hematopoietic Stem Cells
Daniel P. Dever
Stanford University, US
Academic speaker
14:35
15:00
TLA Technology for targeted complete sequencing & haplotyping of (CRISPR) gene editing events; expected and unexpected findings
Erik Splinter
CTO & co-founder, Cergentis, NL
Company speaker
15:00
15:35
Enhancing the CRISPR-Cas genome editing toolbox though structure-guided engineering
Linyi Gao
Zhang Lab - Broad Institute, US
Academic speaker
15:35
15:40
CRISPR/Cas9 knockins – Get better specificity with single-stranded DNA
Cornelia Hampe
Product Manager-Scientific Support Specialist, Takara Bio Europe SAS, FR
Sponsored talk
15:40
15:55
Selected talk: SWITCH: Connecting CRISPR tools for genome engineering and metabolic flux control to develop Saccharomyces cerevisiae cell factories.
Katherina García Vanegas
Technical University of Denmark, DK
Academic speaker
15:55
16:30
Coffee break
Plenary: Therapeutic power of genome engineering
Chair: Silvie Van den Hoecke
16:30
17:05
Determining Regulatory Mechanisms of Human Disease
Tim Reddy
Duke University, US
Academic speaker
17:05
17:40
Engineering Next-Generation T Cells for Cancer Immunotherapy
Yvonne Chen
University of California, US
Academic speaker
17:40
18:15
Therapeutic Strategies Via CRISPR-Cas: New Approaches and New Challenges
Prashant Mali
University of California, US
Academic speaker
18:15
18:25
Closing remarks
Organizing committee
Nico Callewaert
VIB-UGent Center for Medical Biotechnology, BE
Sven Eyckerman
VIB-UGent Center for Medical Biotechnology, BE
Massimo Santoro
VIB-KU Leuven Center for Cancer Biology
Thomas Jacobs
VIB-UGent Center for Plant Systems Biology
Halina Novak
VIB Tech Watch, BE
Silvie Van den Hoecke
VIB Headquarters, BE
Evy Vierstraete
Science Events Manager VIB, BE
Abstracts
The full list of abstracts will be available on 15-01-2018 until 02-02-2018
This list will only be available for registered attendees of the event.
This list will only be available for registered attendees of the event.
Attendees
The full list of attendees will be available on 15-01-2018 until 02-02-2018
This list will only be available for registered attendees of the event.
This list will only be available for registered attendees of the event.
Sponsors
Silver
Silver
Silver
Silver
Silver
Silver
